Polyomavirus and Related Diseases

SEP 7, 2026 · JOURNAL ARTICLE

Three Cases of Merkel Cell Carcinoma Treated With Lutetium‐177 Oxodotreotide

The Journal of Dermatology

Three uncontrolled case reports of a salvage therapy in treatment-refractory merkel cell carcinoma, showing feasibility and safety but limited efficacy; early evidence requiring prospective study.

AUG 18, 2026 · JOURNAL ARTICLE

Ovarian Cancer in Women Living With HIV: Epidemiology, Mechanisms, and Clinical Management

Journal of Immunology and Clinical Microbiology

A narrative review synthesizing heterogeneous observational studies with acknowledged limited and incompletely understood evidence; raises questions about HIV–ovarian cancer association rather than establishing a definitive answer.

AUG 14, 2026 · REVIEW

Merkel cell carcinoma: A clinically oriented mini-review for dermatologists

Dermatology

A clinically oriented mini-review synthesizing current evidence on MCC epidemiology, diagnosis, staging, prognostic factors, and multidisciplinary management for dermatologists; no new primary data or trial results reported.

AUG 13, 2026 · JOURNAL ARTICLE

A case of Merkel cell carcinoma mimicking cellulitis during Janus kinase inhibitor therapy

Journal of Cutaneous Immunology and Allergy

A single case report with atypical clinical presentation and mechanistic speculation; describes one patient's course without a control group or comparative data, raising a signal rather than establishing causation.

AUG 10, 2026 · JOURNAL ARTICLE

Phase II Non-Randomised Trial of Oral Chlorophyllin in Haemorrhagic Cystitis from Radiation Therapy (CLARITY Trial): clinical and quality-of-life outcomes with exploratory proteomics

Scientific Reports

A well-designed single-arm phase II trial with clear efficacy signals (70.8% ORR) and good tolerability, but lacks a control arm and requires randomised confirmation in a larger cohort.

AUG 10, 2026 · JOURNAL ARTICLE

Integration of a multimeric STAT consensus site into the adenoviral genome to interfere with IFN signaling represents a novel concept to improve oncolytic virotherapy

Journal of Virology

Single-centre in vitro work in bladder cancer cells demonstrating a novel viral engineering concept with surrogate endpoints (replication, lysis, particle formation) but no clinical outcomes, animal models, or comparative efficacy data.

JUL 28, 2026 · JOURNAL ARTICLE

Roadmap of MCPyV T-antigens for off-the-shelf therapeutic MCC vaccine development 2309574

The Journal of Immunology

This is an epitope discovery and validation study using in vitro immunological assays and patient-derived models, establishing feasibility for vaccine development but lacking clinical efficacy data or Phase trial results.